Literature DB >> 35997825

Quality of life in patients with early- and late-onset hidradenitis suppurativa.

F Sampogna1, L Fania2, S Mastroeni3, R Fusari3, A Panebianco4, D Abeni3.   

Abstract

Hidradenitis suppurativa (HS) usually has an early onset, however, also onset in the mid-40 s may occur. Recently, the threshold of 28 years to distinguish patients with early and late onset has been proposed. The objective of our study was to compare the quality of life (QoL) and psychological distress in early- and late-onset HS patients. In this cross-sectional, observational study, consecutive patients diagnosed with HS aged ≥ 16 years were recruited. Dermatology-specific QoL was evaluated using the Skindex-17 questionnaire, and psychological distress using the 12-item General Health Questionnaire (GHQ-12). Patients were categorized into "early onset" (< 28 years) and "late onset" (≥ 28 years). Data were collected on 467 patients. Mean age at diagnosis was 21.6 years, with 22.0% of patients presenting with late disease onset. Patients with late onset reported worse psychosocial QoL and higher psychological distress compared to early onset. No differences between the two groups were observed for clinical severity. In the final multivariate model lower diagnostic delay, higher number of fistulae, higher BMI, ex-smoker, no localization on axillae, no localization on mammary region, presence of psoriasis, and higher scores on the psychosocial scale of Skindex-17 were statistically significantly associated with late onset. In conclusion, the psychosocial impact of HS is higher in patients with late onset compared to those with early onset. Differences between these two groups should be further investigated.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Hidradenitis suppurativa; Onset; Psychology; Quality of life; Skindex-17

Year:  2022        PMID: 35997825     DOI: 10.1007/s00403-022-02374-8

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.033


  21 in total

1.  Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.

Authors:  C C Zouboulis; T Tzellos; A Kyrgidis; G B E Jemec; F G Bechara; E J Giamarellos-Bourboulis; J R Ingram; T Kanni; I Karagiannidis; A Martorell; Ł Matusiak; A Pinter; E P Prens; D Presser; S Schneider-Burrus; E von Stebut; J C Szepietowski; H H van der Zee; S M Wilden; R Sabat
Journal:  Br J Dermatol       Date:  2017-10-30       Impact factor: 9.302

2.  Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: evidence from the national Italian registry.

Authors:  V Bettoli; L Naldi; S Cazzaniga; S Zauli; L Atzori; A Borghi; R Capezzera; M Caproni; C Cardinali; V De Vita; M Donini; G Fabbrocini; A Gimma; S Pasquinucci; A Patrizi; A L Pinna; B Raone; M Ricci; A Virgili; R Balestri
Journal:  Br J Dermatol       Date:  2015-11-08       Impact factor: 9.302

3.  Late-onset hidradenitis suppurativa: A cluster analysis of the National Italian Registry IRHIS.

Authors:  Simone Cazzaniga; Elena Pezzolo; Simone Garcovich; Luigi Naldi
Journal:  J Am Acad Dermatol       Date:  2021-03-04       Impact factor: 11.527

4.  The natural history of hidradenitis suppurativa.

Authors:  J M von der Werth; H C Williams
Journal:  J Eur Acad Dermatol Venereol       Date:  2000-09       Impact factor: 6.166

5.  The Broad-Spectrum Impact of Hidradenitis Suppurativa on Quality of Life: A Comparison with Psoriasis.

Authors:  Francesca Sampogna; Luca Fania; Cinzia Mazzanti; Alessio Caggiati; Sabatino Pallotta; Annarita Panebianco; Simona Mastroeni; Biagio Didona; Giusi Pintori; Damiano Abeni
Journal:  Dermatology       Date:  2019-05-23       Impact factor: 5.366

6.  Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation.

Authors:  Christos C Zouboulis; Veronique Del Marmol; Ulrich Mrowietz; Errol P Prens; Thrasivoulos Tzellos; Gregor B E Jemec
Journal:  Dermatology       Date:  2015-06-30       Impact factor: 5.366

Review 7.  Diagnosing Hidradenitis Suppurativa.

Authors:  Jean E Revuz; Gregor B E Jemec
Journal:  Dermatol Clin       Date:  2016-01       Impact factor: 3.478

8.  Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.

Authors:  K Sartorius; L Emtestam; G B E Jemec; J Lapins
Journal:  Br J Dermatol       Date:  2009-04-29       Impact factor: 9.302

9.  The impact of hidradenitis suppurativa on general health is higher than that of hypertension, congestive heart failure, type 2 diabetes, myocardial infarction and depression.

Authors:  F Sampogna; L Fania; C Mazzanti; S Pallotta; A Panebianco; S Mastroeni; B Didona; D Abeni
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-03-04       Impact factor: 6.166

Review 10.  Profound consequences of hidradenitis suppurativa: a review.

Authors:  Ł Matusiak
Journal:  Br J Dermatol       Date:  2018-05-09       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.